Investors

Insider Transactions

Date Name Title Type Shares Traded Sorted Ascending Price Range
Aug 13, 2014 vagelos p roy Officer Sell 8,028 340.01
Oct 4, 2010 vagelos p roy Director Disposition (Non Open Market) 8,035 n/a
Jul 15, 2010 roberts william Officer Acquisition (Non Open Market) 8,041 n/a
Jul 9, 2008 vagelos p roy Director Disposition (Non Open Market) 8,105 n/a
Aug 28, 2008 roberts william Officer Acquisition (Non Open Market) 8,106 n/a
Aug 28, 2008 vagelos p roy Director Disposition (Non Open Market) 8,106 n/a
Nov 13, 2012 goldberg murray a Officer Option Execute 8,176 8.50 - 65.76
Nov 26, 2013 shooter eric m Director Disposition (Non Open Market) 8,185 n/a
Nov 26, 2013 shooter eric m Director Acquisition (Non Open Market) 8,185 n/a
Aug 6, 2014 van plew daniel p Officer Disposition (Non Open Market) 8,194 336.11
May 8, 2013 terifay robert j Officer Sell 8,231 260.86 - 262.06
May 6, 2013 aberman michael s Officer Option Execute 8,334 24.00
Sep 6, 2011 aberman michael s Officer Option Execute 8,334 24.00
May 6, 2013 aberman michael s Officer Sell 8,334 256.46 - 257.29
Nov 29, 2012 aberman michael s Officer Option Execute 8,334 24.00
Dec 14, 2012 stahl neil Officer Automatic Sell 8,386 179.13
Aug 23, 2012 mccorkle douglas s Officer Automatic Sell 8,398 141.85
Dec 14, 2011 stahl neil Officer Automatic Sell 8,411 51.18
Aug 15, 2011 goldberg murray a Officer Automatic Sell 8,591 56.61
Jan 5, 2010 vagelos p roy Director Disposition (Non Open Market) 8,595 n/a
Showing 341-360 of 822 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)